Endometriosis Study
Do you experience endometriosis related pain and fatigue?
Endometriosis affects over 360,000 Australians and is the most common cause of chronic pelvic pain for women. Current non-surgical treatments such as non-steroidal anti-inflammatories, oral contraceptive pills and hormonal treatments have limited effectiveness and the side-effect profile can be troublesome for many women.
NICM researchers are seeking participants to be involved in a clinical trial examining the effectiveness of a modified traditional Chinese herbal medicine for endometriosis related pain and fatigue.
Who can join?
- Women aged 18-45 years living in Australia.
- Women who:
- Have a confirmed diagnosis of endometriosis via laparoscopy in the last five years.
- Have moderate to severe pelvic pain on a regular basis.
- Are not pregnant, breastfeeding or planning to become pregnant in the next three months.
- Have not had surgery on your abdomen in the last six months.
- Have not started or stopped any treatments for your endometriosis in the last six months.
What's involved?
- After an initial assessment and consent, you will:
- Complete a short online diary once a day for a month, to evaluate your eligibility to participate in this clinical trial and to assess your current level of endometriosis related pain.
- Have blood taken to assess your liver and kidney function.
- Participants will be randomly allocated into a treatment group (active or placebo). Over the three-month study, participants will be asked to:
- Take six capsules per day.
- Complete a short online diary form once a day.
- After treatment:
- Have blood taken.
- Complete a short online questionnaire one month after the last capsule.
What are the benefits of participating?
- If you currently experience endometriosis related chronic pelvic pain you may get a reduction in either your pelvic pain or fatigue from taking the study medication.
- Once you have completed the study, and if you were in the placebo group, you are eligible to receive a three month complimentary supply of the active treatment.
For more details about this study please read the following information before deciding on whether to participate or not.
- Participation Information Sheet and Consent Form (PDF, 323 KB) (opens in a new window)
Interested in participating in this study?
In order to confirm your eligibility and register your interest, please complete the online screening form below.
- Online screening form for endometriosis study (opens in a new window)
For more information please contact:
Mahmoud Al-Dabbas
NICM Research Officer
e. m.al-dabbas@westernsydney.edu.au
p. (02) 9685 4736
m. 0414 357 363
Human Research Ethics Committee Approval: This clinical trial has been approved by Western Sydney University Human Research Ethics Committee (Approval Number: H13256).
This study is supported by a Partnership Grant between Metagenics and Western Sydney University.
Chief Investigator: Dr Mike Armour, NICM Health Research Institute